NCT04282837 is a clinical trial of AI classification of patients with obesity in Obesity, sponsored by Shanghai 10th People's Hospital.

Who is sponsoring NCT04282837?

NCT04282837 is sponsored by Shanghai 10th People's Hospital.

What drugs are being tested in NCT04282837?

Interventions in NCT04282837: AI classification of patients with obesity.

Is NCT04282837 still recruiting?

NCT04282837 is currently completed. Last updated 25 June 2020.

Last reviewed 2020-06-25 · How we verify

NCT04282837

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Machine Learning for Reclassification of Obesity

Completed Last updated 25 June 2020

What this trial tests

trial testing AI classification of patients with obesity in Obesity in 2,495 participants. Completed in 20 June 2020.

Timeline

1 March 2020

Primary endpoint
30 April 2020

20 June 2020

Quick facts

Lead sponsor	Shanghai 10th People's Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,495
Start date	1 March 2020
Primary completion	30 April 2020
Estimated completion	20 June 2020
Sites	1 location across China

Drugs / interventions tested

AI classification of patients with obesity

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

Shanghai 10th People's Hospital

Who can join

Adults 10 to 70, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to employ or develop computational modeling techniques for the precise reclassification of obesity into subgroups. Clinical features, risks of noncommunicable diseases, as well as weight loss effects of bariatric surgery will also be studied and compared within the subgroups.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study.
Lin Z, Feng W, Liu Y, Ma C, et al · · 2021 · cited 38× · PMID 34335479 · DOI 10.3389/fendo.2021.713592
A multi-center study on glucometabolic response to bariatric surgery for different subtypes of obesity.
Liu Y, Sheng C, Feng W, Sun F, et al · · 2022 · cited 4× · PMID 36407309 · DOI 10.3389/fendo.2022.989202
Precision nutrition-based interventions for the management of obesity in children and adolescents up to the age of 19 years.
Huey SL, Mehta NH, Steinhouse RS, Jin Y, et al · · 2025 · cited 2× · PMID 39882755 · DOI 10.1002/14651858.cd015877

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Shanghai 10th People's Hospital trials

Trials by the same sponsor.

NCT07528040 — An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With C · not yet recruiting
NCT07370441 — Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients · Phase 4 · not yet recruiting
NCT07328100 — Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. · NA · not yet recruiting
NCT06783296 — Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension · NA · not yet recruiting
NCT07204496 — A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04282837 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai 10th People's Hospital
Last refreshed: 25 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04282837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing